CGNH Financials 07/16/2014 07:19:38
CardioGenics Holdings Inc.
Period Ending Oct 31, 2013 Oct 31, 2012 Oct 31, 2011 Oct 31, 2010
Total Revenue - 1 9 -
Cost of Revenue - - - -
Gross Profit - 1 9 -
Operating Expenses
Research and Development 419 523 426 606
Sales, General and Admin. 2,086 742 5,153 1,247
Non-Recurring Items - 25 56 105
Other 22 25 26 24
Operating Income (2,527) (1,314) (5,651) (1,982)
Income From Continuing Operations
Add'l Income/Expense Items (110) 19 (91) (104)
Earnings Before Interest and Tax (2,637) (1,295) (5,742) (2,086)
Interest Expense 300 22 20 30
Earnings Before Tax (2,937) (1,316) (5,762) (2,116)
Income Tax - - - -
Minority Interest (18) ( (37) (14)
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,937) (1,316) (5,762) (2,102)
Non Recurring Events
Discontinued Operations - - - 78
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,919) (1,308) (5,725) (2,024)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,919) (1,308) (5,725) (2,024)